MeVis Medical Solutions AG

  • WKN: A0LBFE
  • ISIN: DE000A0LBFE4
  • Land: Germany

Nachricht vom 07.05.2012 | 15:59

MeVis Medical Solutions AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


MeVis Medical Solutions AG 

07.05.2012 15:59

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


On May 7, 2012, M.M.Warburg & CO KGaA, Hamburg, Germany has informed
us according to Article 21, Section 1 of the WpHG that via shares its
Voting Rights on MeVis Medical Solutions AG, Bremen, Germany, have fallen
below the 5 % and the 3 % threshold of the Voting Rights, mentioned in
Article 21, Section 1 of the WpHG, on May 2, 2012 and on that day amounted
to 0.997 % (this corresponds to 18157 Voting Rights).

Additionally, M.M.Warburg & CO KGaA, Hamburg, Deutschland, has informed us
according to Article 21, Section 1 of the WpHG on May 7, 2012, that via
shares its Voting Rights of M.M.Warburg & CO Gruppe (GmbH & Co.) KGaA,
Hamburg, Germany on MeVis Medical Solutions AG, Bremen, Germany, have
fallen below the 5 % and the 3 % threshold of the Voting Rights, mentioned
in Article 21, Section 1 of the WpHG, on May 2, 2012 and on that day
amounted to 0.997 % (this corresponds to 18157 Voting Rights).

All of these Voting Rights are to be attributed to M.M.Warburg & CO Gruppe
(GmbH & Co.) KGaA according to Article 22, Section 1, Sentence 1, No. 1
WpHG. Name of the controlled entity is the M.M.Warburg & CO KGaA.



07.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      MeVis Medical Solutions AG
              Universitätsallee 29
              28359 Bremen
              Germany
Internet:     http://www.mevis.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Event im Fokus

38. m:access Analystenkonferenz München

Datum: 06.06.2013
Zeit: 9:30 Uhr - 17.00 Uhr
Ort: Börse München



Aktuelle Research-Studie

Original-Research: getgoods.de Anleihe (von GBC AG): stark überdurchschnittlich attraktiv getgoods.de Anleihe

24. Mai 2013